Subscribe on Amazon Music, Apple Podcasts, Audacy, Audible, Deezer, Goodpods, iHeartRadio, Overcast, Pandora, PlayerFM, Pocket Casts, Spotify, YouTube, YouTube Music.
The U.S. Food and Drug Administration’s (FDA’s) broad definition of “misbranding” has created some industry confusion, while the Federal Trade Commission’s (FTC’s) updates to its Health Products Compliance Guidance have done the same.
In light of these recent actions, what challenges are dietary supplement manufacturers now facing?
On this episode, Epstein Becker Green attorneys Jack Wenik, Teddy McCormick, Zach Taylor, and Tracey Gonzalez discuss recent updates to the FDA and FTC guidelines as they apply to dietary supplement manufacturers, as well as new developments with respect to misbranding.
About the Diagnosing Health Care Podcast
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Trouble listening to this podcast? Please contact us at thisweek@ebglaw.com and mention whether you were at home or working within a corporate network. We'd also love to hear your suggestions for future episode topics.
Subscribe to the Podcast
Never miss an episode! Subscribe to Diagnosing Health Care on your preferred platform – Amazon Music, Apple Podcasts, Audacy, Audible, Deezer, Goodpods, iHeartRadio, Overcast, Pandora, PlayerFM, Pocket Casts, Spotify, YouTube, YouTube Music.
.
Spread the Word
Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition on LinkedIn, Facebook, X, YouTube, and YouTube Music, and your connections can subscribe for email notifications.
